Study finds evidence for repurposing thiostrepton as an anti-rhabdomyosarcoma drug Post author:admin Post published:October 27, 2025 Post category:uncategorized Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. You Might Also Like Water distribution cabinets with floor heating pose Legionnaires’ disease risk October 30, 2023 WHO launches AI-powered empathetic digital health promoter April 4, 2024 Harvard researchers map 70,000 synaptic connections in rat brain February 14, 2025